Literature DB >> 2829177

ATP stimulates the binding of simian virus 40 (SV40) large tumor antigen to the SV40 origin of replication.

J A Borowiec1, J Hurwitz.   

Abstract

Simian virus 40 (SV40) large tumor antigen (T antigen) binds to two contiguous sites at the SV40 origin of replication. Of these two sites, I and II, only site II is critical for replication. We have studied the interaction between T antigen and these sites by two methods--nitrocellulose filter binding and DNase I protection. We show that T antigen binds with high occupancy to site I at 0 degrees C, 25 degrees C, and 37 degrees C but to site II only at 0 degrees C and 25 degrees C. At 37 degrees C, the temperature essential for the initiation of SV40 DNA replication in vitro, ATP is required for the interaction of T antigen and site II. ATP can be replaced efficiently by adenosine 5'-[beta,gamma-imido]triphosphate and ADP, suggesting that hydrolysis of the nucleotide is not essential for the binding of T antigen to site II. The binding to the region critical for replication can occur in the presence of a variety of nucleoside triphosphates; dATP supports binding at a concentration 1/30th that of ATP, while dGTP and rGTP were inactive at all concentrations tested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829177      PMCID: PMC279482          DOI: 10.1073/pnas.85.1.64

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Protein-DNA interactions at the origin of simian virus 40 DNA replication.

Authors:  R Tjian
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1979

2.  ATP-dependent formation of a specialized nucleoprotein structure by simian virus 40 (SV40) large tumor antigen at the SV40 replication origin.

Authors:  F B Dean; M Dodson; H Echols; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Mutational analysis of the simian virus 40 replicon: pseudorevertants of mutants with a defective replication origin.

Authors:  D R Shortle; R F Margolskee; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Variation of the average rotation angle of the DNA helix and the superhelical turns of covalently closed cyclic lambda DNA.

Authors:  J C Wang
Journal:  J Mol Biol       Date:  1969-07-14       Impact factor: 5.469

5.  Detection and characterization of multiple forms of simian virus 40 large T antigen.

Authors:  E Fanning; B Nowak; C Burger
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Construction and analysis of simian virus 40 origins defective in tumor antigen binding and DNA replication.

Authors:  R M Myers; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Binding of an SV40 T antigen-related protein to the DNA of SV40 regulatory mutants.

Authors:  R McKay; D DiMaio
Journal:  Nature       Date:  1981-02-26       Impact factor: 49.962

9.  Complex of simian virus 40 large tumor antigen and 48,000-dalton host tumor antigen.

Authors:  D S Greenspan; R B Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  Binding of the recA protein of Escherichia coli to single- and double-stranded DNA.

Authors:  K McEntee; G M Weinstock; I R Lehman
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  77 in total

1.  A ring-opening mechanism for DNA binding in the central channel of the T7 helicase-primase protein.

Authors:  P Ahnert; K M Picha; S S Patel
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Peptides containing cyclin/Cdk-nuclear localization signal motifs derived from viral initiator proteins bind to DNA when unphosphorylated.

Authors:  Ronald J Kim; Stephanie Moine; Danielle K Reese; Peter A Bullock
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Simian virus 40 DNA replication in vitro: identification of multiple stages of initiation.

Authors:  T Tsurimoto; M P Fairman; B Stillman
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

4.  Mechanism of activation of simian virus 40 DNA replication by protein phosphatase 2A.

Authors:  D M Virshup; A A Russo; T J Kelly
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

5.  Functional characterization of temperature-sensitive mutants of simian virus 40 large T antigen.

Authors:  S Ray; M E Anderson; G Loeber; D McVey; P Tegtmeyer
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  Spacing is crucial for coordination of domain functions within the simian virus 40 core origin of replication.

Authors:  R Parsons; P Tegtmeyer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Large T-antigen mutants define multiple steps in the initiation of simian virus 40 DNA replication.

Authors:  I J Mohr; M P Fairman; B Stillman; Y Gluzman
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Multiple functions of human single-stranded-DNA binding protein in simian virus 40 DNA replication: single-strand stabilization and stimulation of DNA polymerases alpha and delta.

Authors:  M K Kenny; S H Lee; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Origin auxiliary sequences can facilitate initiation of simian virus 40 DNA replication in vitro as they do in vivo.

Authors:  Z S Guo; C Gutierrez; U Heine; J M Sogo; M L Depamphilis
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

10.  Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.

Authors:  S R Kyöstiö; R S Wonderling; R A Owens
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.